Kazano (alogliptin/metformin) / Takeda  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kazano (alogliptin/metformin) / Takeda
NCT02989649: Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Terminated
N/A
593
RoW
Alogliptin, Alogliptin FDC With Pioglitazone, Alogliptin FDC With Metformin
Takeda
Diabetes Mellitus, Type 2
01/18
01/18
NCT03555565: Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"

Completed
N/A
1026
Japan
Alogliptin and Metformin hydrochloride, Inisync combination tablets
Takeda
Type 2 Diabetes Mellitus
10/19
10/19

Download Options